Estharla Madhu Rekha

发表

Discovery and evaluation of novel Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors as therapeutic drug leads

Luke W. Guddat, Shan Zheng, Dharmarajan Sriram, 2019, Journal of Computer-Aided Molecular Design.